跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CS-21
首页
药物
CS-21
CS-21
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
RNA interference factor loaded temperature-sensitive biomimetic material for uterine cavity repair and preparation method of RNA interference factor loaded temperature-sensitive biomimetic material
申请人: FUXING HOSPITAL CAPITAL MEDICAL UNIV
优先权: 2025
CN
Hybridoma cell strain 1G1 capable of secreting plasmodium CSP recombinant protein monoclonal antibody and application of hybridoma cell strain 1G1
申请人: LANZHOU INST OF BIOLOGICAL PRODUCTS CO LTD
优先权: 2024
CN
Hybridoma cell strain 3F9 capable of secreting plasmodium CSP recombinant protein monoclonal antibody and application of hybridoma cell strain 3F9
申请人: LANZHOU INST OF BIOLOGICAL PRODUCTS CO LTD
优先权: 2024
CN
Preparation method for oral protein immune carrier
申请人: UNIV CHINA PHARMA
优先权: 2016
CN
Macrocyclic quinazoline derivatives as antiproliferative agents
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2003
US
药物
反馈